| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Molecular Biology, Cancer Research Institute, Kanazawa University, Takara-machi 13-1, Kanazawa 920, Japan
Transactivation of viral and host genes expression by hepatitis B virus X protein (HBx) is believed to be involved in hepatocarcinogenesis. The interaction of HBx with the tumor suppressor p53 and its inhibitory effect on p53 functions have been reported recently. However, the question of whether p53 is directly involved in HBx transactivation has not yet been addressed. In this study, we delineated the interaction sites of HBx and p53 using far-Western blotting and glutathione S-transferase-resin pulldown assays. The results indicate that the HBx-binding sites are located within the oligomerization and specific DNA-binding domains of p53 and that the p53-binding site was confined to a small region in the HBx transactivation domain. Mutual interference of the transactivations by HBx and p53 was detected by CAT assays in a transient transfection system. Strikingly, transactivation by HBx was observed in the p53-negative cells, Saos-2 and Hep3B, indicating that the transactivation and the p53-inhibiting functions of HBx are mutually interfering but distinct.
1 This study was partly supported by a Science Grant from the Ministry of Education and Culture of Japan.
2 To whom requests for reprints should be addressed. Phone: 81-76-265-2731; Fax: 81-76-234-4501; E-mail: semuraka@kenroku.ipc.kanazawa-u.ac.jp.
Received 6/12/97. Accepted 9/19/97.
This article has been cited by other articles:
![]() |
X. Liu, L. Wang, S. Zhang, J. Lin, S. Zhang, M. A. Feitelson, H. Gao, and M. Zhu Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses Carcinogenesis, June 1, 2008; 29(6): 1207 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Chiu, S.-H. Yeh, P.-J. Chen, T.-J. Kuo, C.-J. Chang, P.-J. Chen, W.-J. Yang, and D.-S. Chen Inaugural Article: Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level PNAS, February 20, 2007; 104(8): 2571 - 2578. [Abstract] [Full Text] [PDF] |
||||
![]() |
N H Park, I H Song, and Y-H Chung Chronic hepatitis B in hepatocarcinogenesis. Postgrad. Med. J., August 1, 2006; 82(970): 507 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Kwun and K. L. Jang Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene Nucleic Acids Res., April 23, 2004; 32(7): 2202 - 2213. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-G. Yoo, S. H. Oh, E. S. Park, H. Cho, N. Lee, H. Park, D. K. Kim, D.-Y. Yu, J. K. Seong, and M.-O. Lee Hepatitis B Virus X Protein Enhances Transcriptional Activity of Hypoxia-inducible Factor-1{alpha} through Activation of Mitogen-activated Protein Kinase Pathway J. Biol. Chem., October 3, 2003; 278(40): 39076 - 39084. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. LEVY, C. A. RENARD, Y. WEI, and M. A. BUENDIA Genetic Alterations and Oncogenic Pathways in Hepatocellular Carcinoma Ann. N.Y. Acad. Sci., June 1, 2002; 963(1): 21 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hay and G. Kannourakis A time to kill: viral manipulation of the cell death program J. Gen. Virol., June 1, 2002; 83(7): 1547 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Arai, K. Masutomi, S. Khurts, S. Kaneko, K. Kobayashi, and S. Murakami Two Independent Regions of Human Telomerase Reverse Transcriptase Are Important for Its Oligomerization and Telomerase Activity J. Biol. Chem., March 1, 2002; 277(10): 8538 - 8544. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Groisman, R. Koshy, F. Henkler, J. D. Groopman, and M. A. Alaoui-Jamali Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells Carcinogenesis, March 1, 1999; 20(3): 479 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Prost, J. M. Ford, C. Taylor, J. Doig, and D. J. Harrison Hepatitis B x Protein Inhibits p53-dependent DNA Repair in Primary Mouse Hepatocytes J. Biol. Chem., December 11, 1998; 273(50): 33327 - 33332. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dorjsuren, Y. Lin, W. Wei, T. Yamashita, T. Nomura, N. Hayashi, and S. Murakami RMP, a Novel RNA Polymerase II Subunit 5-Interacting Protein, Counteracts Transactivation by Hepatitis B Virus X Protein Mol. Cell. Biol., December 1, 1998; 18(12): 7546 - 7555. [Abstract] [Full Text] |
||||
![]() |
Y. Lin, H. Tang, T. Nomura, D. Dorjsuren, N. Hayashi, W. Wei, T. Ohta, R. Roeder, and S. Murakami The Hepatitis B Virus X Protein Is a Co-activator of Activated Transcription That Modulates the Transcription Machinery and Distal Binding Activators J. Biol. Chem., October 16, 1998; 273(42): 27097 - 27103. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Elmore, A. R. Hancock, S.-F. Chang, X. W. Wang, S. Chang, C. P. Callahan, D. A. Geller, H. Will, and C. C. Harris Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis PNAS, December 23, 1997; 94(26): 14707 - 14712. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Masutomi, S. Kaneko, N. Hayashi, T. Yamashita, Y. Shirota, K. Kobayashi, and S. Murakami Telomerase Activity Reconstituted in Vitro with Purified Human Telomerase Reverse Transcriptase and Human Telomerase RNA Component J. Biol. Chem., July 14, 2000; 275(29): 22568 - 22573. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Goto, N. Kato, S. K. Ono-Nita, H. Yoshida, M. Otsuka, Y. Shiratori, and M. Omata Large Isoform of Hepatitis Delta Antigen Activates Serum Response Factor-associated Transcription J. Biol. Chem., November 22, 2000; 275(48): 37311 - 37316. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wei, D. Dorjsuren, Y. Lin, W. Qin, T. Nomura, N. Hayashi, and S. Murakami Direct Interaction between the Subunit RAP30 of Transcription Factor IIF (TFIIF) and RNA Polymerase Subunit 5, Which Contributes to the Association between TFIIF and RNA Polymerase II J. Biol. Chem., April 6, 2001; 276(15): 12266 - 12273. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |